Aarkstore.com announce a new report "T-Cell Lymphomas – Pipeline Review, H1 2012" through its vast collection of market research report.

1. Aarkstore.com announces, a new market research report is available in its vast collection
T-Cell Lymphomas – Pipeline Review, H1 2012
http://www.aarkstore.com/reports/T-Cell-Lymphomas-Pipeline-Review-H1-2012-200360.html
RSS FEED:
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary:
Global Markets Direct’s, T-Cell Lymphomas - Pipeline Review, H1 2012, provides an
overview of the T-Cell Lymphomas therapeutic pipeline. This report provides
information on the therapeutic development for T-Cell Lymphomas, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for T-Cell Lymphomas.
Scope:
- A snapshot of the global therapeutic scenario for T-Cell Lymphomas.
- A review of the T-Cell Lymphomas products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy:
- Identify and understand important and diverse types of therapeutics under
development for T-Cell Lymphomas.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.

2. Table of Contents :
List of Tables 5
List of Figures 6
Introduction 8
Global Markets Direct Report Coverage 8
T-Cell Lymphomas Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for T-Cell Lymphomas 10
T-Cell Lymphomas Therapeutics under Development by Companies 12
T-Cell Lymphomas Therapeutics under Investigation by Universities/Institutes 15
Late Stage Products 19
Comparative Analysis 19
Mid Clinical Stage Products 20
List of Tables:
Number of Products Under Development for T-Cell Lymphomas, H1 2012 16
Products under Development for T-Cell Lymphomas – Comparative Analysis, H1
2012 17
Number of Products under Development by Companies, H1 2012 19
Number of Products under Development by Companies, H1 2012 (Contd..1) 20
Number of Products under Investigation by Universities/Institutes, H1 2012 22
Number of Products under Investigation by Universities/Institutes, H1 2012
(Contd..1) 23

3. More Report:
Thymus Cancer – Pipeline Review, H1 2012
Vulvar Cancer – Pipeline Review, H1 2012
Soft Tissue Sarcoma – Pipeline Review, H1 2012
Germ Cell Tumors – Pipeline Review, H1 2012
Systemic Juvenile Idiopathic Arthritis (SJIA) – Pipeline Review, H1 2012
More Related Reports:
T-Cell Lymphomas Global Clinical Trials Review, H1, 2012
T-Cell Lymphomas - Pipeline Review, H2 2011
T-Cell Lymphomas - Pipeline Review, Q4 2010
T-cell Lymphomas Global Clinical Trials Review, Q4, 2010
From: Aarkstore Enterprise
Contact: Marketing Team(Dipti)
Mob.No.918149852585/919272852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com/
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore